Document is current
Any future updates will be listed below
-
Authors
Noorduyn, Stephen G. https://orcid.org/0000-0002-5936-5579
Begaj, Kejsi
Martin, Amber
Forero-Schwanhaeuser, Sergio
Schaible, Kassandra
Moore, Alison
Paczkowski, Rosirene
-
Funding
Funding for this research was provided by:
GSK (222898)
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 7 February 2025
First Online: 6 March 2025
Declarations
:
: Stephen G. Noorduyn, Sergio Forero-Schwanhaeuser, Alison Moore, and Rosirene Paczkowski are employees of GSK and hold financial equities in GSK. Kejsi Begaj is an employee of GSK contracted through the Rutgers Health Outcomes, Policy, and Economic (HOPE) program, and does not hold any financial equities in GSK. Amber Martin and Kassandra Schaible are employees of Evidera Inc., a part of Thermo Fisher Scientific, which received funding from GSK to conduct the study.
: No ethical approval was required for this study as no human participants were recruited or animals used.
